Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Aizen J. Marrogi"'
Autor:
Lynn I. Levin, Christina M. Ramirez, Eileen L. Liao, Hongyu Guo, Bong K. Kim, Aizen J. Marrogi, Larry I. Magpantay, Elizabeth C. Breen, Otoniel Martínez-Maza
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
Background: To examine the contribution of B-cell activation molecules to B-cell follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL), a prospective study was conducted using pre-diagnosis serial serum samples from the US Department of
Selective Oxidation of Alcohols with a New Reagent: Iron(III) Nitrate Supported on Aluminum Silicate
Publikováno v:
Synthetic Communications. 38:428-433
A selective and effective oxidation of alcohols, except aliphatic alcohols, such as 1‐hexanol or 1‐octyl alcohol, to the corresponding aldehydes and ketones using a new reagent, iron(III) nitrate supported on aluminum silicate, under heterogeneou
Autor:
Kangmin Zhu, Charles R. Mulligan, Amir D. Meram, Aizen J. Marrogi, Courtney D. Proctor, Hongyu Wu
Publikováno v:
The Annals of Thoracic Surgery. 82:220-226
Background The purpose of this study is to determine a more refined T definition for lung cancer staging on the basis of clinical outcomes. Methods The Walter Reed Army Medical Center Tumor Registry and the Thoracic Surgery Tumor Clinic files were qu
Autor:
Charles R. Mulligan, Kangmin Zhu, Amir D. Meram, Aizen J. Marrogi, Courtney D. Proctor, Hongyu Wu
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 15:25-31
Study Objective: Evaluate the prognostic factors influencing lung cancer survival under a universal health care system and determine if access to care eliminates clinical outcome disparity. Design: Retrospective case series review. Background: Lung c
Autor:
Kevin E. McCarthy, P Byrne, Lynn Harrison, Aizen J Marrogi, Jay K. Kolls, Paul Schwarzenberger
Publikováno v:
The Annals of Thoracic Surgery. 70:407-411
Background . Malignant mesothelioma is an uncommon but lethal cancer of increasing incidence, particularly among patients with a history of exposure to asbestos. Although numerous treatments have been employed, including chemotherapy, radiation thera
Publikováno v:
Archives of Pathology & Laboratory Medicine. 123:310-316
Low malignant potential tumors of the ovary are believed to behave in a manner intermediate to their benign and malignant counterparts. However, recent evidence suggests these lesions are in fact benign and better classified as proliferative. Based o
Publikováno v:
International Journal of Cancer. 80:380-386
Tumor cells genetically modified with the herpes simplex virus thymidine kinase (HSV-tk) gene in combination with ganciclovir (GCV) demonstrate a "bystander effect". Previous attempts to enhance the bystander tumor killing by combining cytokine genes
Publikováno v:
Monatshefte für Chemie - Chemical Monthly. 139:609-611
A new, general, and efficient technique for the reaction of solid substrates under viscous conditions with shaking at room temperature is described, which can overcome some of the problems existing in common solvent-free reactions solids as the start
Autor:
Lynn Harrison, Ann Weinacker, Richard Gaumer, Aizen J. Marrogi, P Byrne, Chris Theodossiou, Jay K. Kolls, Warren R. Summer, Paul Schwarzenberger, Scott M. Freeman, Rajagopal Ramesh
Publikováno v:
Human Gene Therapy. 9:2641-2649
Malignant mesothelioma is a tumor of the pleura for which there is no satisfactory treatment. It is almost universally fatal, regardless of the stage of the tumor at the time of diagnosis. Current treatment modalities include surgery, chemotherapy, a
Autor:
Jay K. Kolls, Chris Theodossiou, Scott M. Freeman, P Byrne, Principal Investigator: Paul Schwarzenberger, Ann Weinacker, Aizen J. Marrogi, Richard Gaumer, Co-Investigators: Lynn Harrison, Rajagopal Ramesh, Study Contact: Judy Norton, Warren R. Summer
Publikováno v:
Human Gene Therapy. 9:2641-2649
Malignant mesothelioma is a tumor of the pleura for which there is no satisfactory treatment. It is almost universally fatal, regardless of the stage of the tumor at the time of diagnosis....